Who are the main actors of cardiac device follow-up? Analysis of the super follow-up study termine this percentage according to the device calculation. Because device will show total percentage of both RV and LV pacing (only one manufacture shows RV and LV separately), however only 12-lead ECG will ensure biventricular pacing. As far as we know that industry representatives do not check 12-lead ECG in patients with CRT during the interrogation. This issue needs to be solved only by cardiac electrophysiologits and/or device specialists.
5. Another unmentioned issue is device recalls. Unfortunately, device recalls and advisories are not taken seriously in our country. Both companies and physicians should act together and keep the patients informed regarding device recalls (4) .
Finally, we would like to provide solutions to improve device follow-up in developing countries: a) Specialists specializing in rhythm disorders: Unfortunately, in developing countries, there are no fellowship programs; however, in North America (USA and Canada) and European countries, cardiac electrophysiology training (1-2 years) is essential to perform in-and outpatient arrhythmia service. b) Dedicated Cardiac Rhythm and Device Management clinics (electrophysiologists and/or device technicians) c) Implantation of more technologically advanced devices is also very useful because it will improve follow-up of patients with pacemakers and ICD/CRTD. Due to economic issues in developing countries, there are still big public centers that implant basic devices instead of new, smarter, MRI-compatible devices.
d) Trainings and educational courses offered by companies to health-care workers may prove invaluable.
In conclusion, we congratulate Üreyen et al. (1) for their insightful study. As a cardiac electrophysiologist trained in Canada, I am proud of my colleagues that they increased awareness of this important issue.
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